BioExx Granted ISO 22000, HACCP and GMP Certification
October 26 2009 - 6:00AM
Marketwired
Bio-Extraction Inc. (TSX VENTURE: BXI) ("BioExx" or "the Company")
is pleased to announce that it has received a Certificate of
Registration that certifies that the Food Safety Management System
of BioExx Specialty Proteins Inc. ("BSPI") has been assessed by
NSF-ISR and found to be in conformance with ISO 22000:2005 where
the Scope of Registration is Canola oilseed processing. NSF-ISR is
a not- for-profit, non-governmental organization that is the world
leader in standards development, product certification, education,
and risk-management for public health and safety. BSPI is a wholly
owned subsidiary of Bio-Extraction Inc. and is the owner and
operator of the Company's canola processing facility in Saskatoon.
ISO 22000:2005 requires that all hazards that may be reasonably
expected to occur in the food chain, including hazards that may be
associated with the type of process and facilities used, are
identified and assessed. Thus it provides the means to determine
and document why certain identified hazards need to be controlled
by a particular organization and why others need not. ISO 22000
integrates the principles of the Hazard Analysis and Critical
Control Point (HACCP) system and application steps developed by the
Codex Alimentarius Commission.
To successfully complete the ISO 22000:2005 audit, an applicant
must also demonstrate that it has adequately installed both HACCP
and GMP procedures and is practicing both to a level that is
consistent with the requirements set out under ISO 22000:2005.
HACCP is internationally recognized as the primary means for
enhancing food safety throughout the food chain, and is
increasingly being used around the world. HACCP, or, Hazard
Analysis Critical Control Points, is a standard designed to
prevent, reduce or eliminate potential biological, chemical and
physical food safety hazards.
Good manufacturing practices or "GMP" is a term that is
recognized worldwide for the control and management of
manufacturing and quality control of foods, pharmaceutical
products, and medical devices. GMPs are guidelines that outline the
aspects of production that would affect the quality of a product.
In Canada, GMP is controlled and monitored by Health Canada.
"We are very proud of our Saskatoon team for achieving this
important certification so early in the plant life-cycle. While
firmly expected, we do believe this is an important milestone as it
demonstrates a readiness to manage the critical issue of food
safety, and the additional controls that will be required, as we
commence our specialty protein production," says BioExx CEO Chris
Carl. "We also believe that this is exemplary of the very strong
importance that senior management puts on quality in every aspect
of our operations."
ABEX Award
BioExx is very proud to announce that it is the recipient of the
2009 Achievement for Business Excellence (ABEX) Award in the
category of Technology-In-Action New Saskatchewan Product. The
award, which was issued by the Saskatchewan Chamber of Commerce on
Saturday, October 24th, and sponsored by the Saskatchewan Research
Council, goes to a business demonstrating exceptional performance
in launching a new Saskatchewan- made product, technology or
service, which is original and has strong commercial potential.
Laurence Parslow, General Manager of the Saskatoon Plant and
Director of Research and Development for BioExx, accepted the
award. "It is a great honour to be recognized in our community
among so many other excellent Saskatchewan companies," said Mr.
Parslow. "We are very excited about the new canola based protein
products that we are bringing to market and we look forward to
continued success working with some of the best minds and research
organizations in the industry here in Saskatchewan."
The award also includes a $10,000 monetary prize provided by
SRC's Technology-in-Action Fund. BioExx intends to use the funds
either to make a donation, or to create a program of its own, aimed
at assisting others in furthering their post-secondary,
science-related education in Saskatchewan.
About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology
and industrial processing company focused on the extraction of oil
and high-value proteins from oilseeds for the global food,
beverage, and nutrition markets. BioExx's patented technology
allows for the use of significantly lower temperatures than
conventional methods in extracting the active ingredients and oils
from oilseeds, resulting in higher yields and higher-quality meal,
oils and proteins. BioExx's low energy requirements,
environmentally sound process, and high-yield production have the
potential to make a valuable contribution in alleviating food
scarcity. BioExx operates a commercial scale extraction facility in
Saskatoon, Saskatchewan, and has a mission to construct additional
and larger processing facilities on a global basis. To find out
more about Bio-Extraction Inc. (TSX VENTURE: BXI), please visit
www.bioexx.com
The statements made in this press release include
forward-looking statements that involve a number of risks and
uncertainties. These statements relate to future events or future
performance and reflect management's current expectations and
assumptions. A number of factors could cause actual events,
performance or results to differ materially from the events,
performance and results discussed in the forward-looking
statements, such as the economy, generally, competition in its
target markets, the demand for BioExx's products, the availability
of funding, the efficacy of its technology, and the anticipated
costs of BioExx's plant construction and operation. These
forward-looking statements are made as of the date hereof and
BioExx does not assume any obligation to update or revise them to
reflect new events or circumstances. Actual events or results could
differ materially from BioExx's expectations and projections."
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: Bio-Extraction Inc.: Chris Schnarr Chief Financial
Officer (416) 588-4442 x111 cschnarr@bioexx.com Investor Relations:
Scott Koyich President, Brisco Capital Partners (403) 262-9888
scott@briscocapital.com
Bioexx Specialty Proteins Ltd Com Npv (TSXV:BXI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bioexx Specialty Proteins Ltd Com Npv (TSXV:BXI)
Historical Stock Chart
From Sep 2023 to Sep 2024